Healthcare Private Equity Investors Tackle Regulatory Challenges
How private equity investors active in the healthcare industry are responding to government inquiries on rollups
Policy Updates
New Merger Guidelines Increase Risks for PE, Mid-Market Deals
PE firms should not assume that a transaction will fly under the radar simply because of a relatively low value
For Private Equity, the New Year Rings in New Regulatory Pressures
As dealmakers look to 2024, there is a host of new rules or proposed rules that private equity firms need to either adhere to or keep a close eye on
Investing in Ideals: A Conversation with Penny Pritzker
Penny Pritzker joins GrowthTV to discuss how she navigates the unique challenges of 2023
Wading Through the Data of M&A Forecasts
We combed through industry research and talked to three experts to get the skinny on what PE can expect for dealmaking this year
Divided Congress Limits Legislative Possibilities, Shifts Focus to Financial Regulators
Trade is among the areas for bipartisanship in a divided Congress, while regulatory activity ramps up and the debt ceiling looms
When Hiring a CFO, PE Firms Refuse to Settle
Amid macroeconomic pressures, PE firms need CFOs who can turn challenges into opportunities
Without SAFE Banking Act’s Passage, What’s Next for Cannabis M&A?
Congress failed to pass the SAFE Banking Act in its lame-duck session. Burns & Levinson attorneys share what that means for dealmakers
3 Areas of Private Equity the SEC Is Watching in 2023
Recent SEC initiatives raise concerns for middle-market PE firms